Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
epidural double lumen lidoderm scopolamine phenylepherene sciatica est pain control pregnancy intubationYour Article Summary
See Latest ArticlesMulticenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: The alternative dosing for outpatient treatment (ADOPT) trial
Journal of Clinical Oncology, 08/11/09
Steensma DP et al. – Decitabine given on a 5–day schedule provided meaningful clinical benefit for patients with MDS, with more than half demonstrating improvement. This suggests that decitabine can be administered in an outpatient setting with comparable efficacy and safety to the United States Food and Drug Administration–approved inpatient regimen.
Related Articles
Azacytidine Inhibits RNA Methylation at DNMT2 Target Sites in Human Cancer Cell Lines
Cancer Research, 10/21/09
Relevance Score: 80%
Today in Ambulatory...keeping you current
Receive free subspecialty "5-minute updates" via email
Sevoflurane with or without antiemetic prophylaxis of dexamethasone in spontaneously breathing patients undergoing outpatient anorectal surgery
Journal of Clinical Anesthesia, 12/15/09
Ambulatory inguinal herniorrhaphy: paravertebral block versus spinal anesthesia
Minerva Anestesiologica, 12/01/09
Systemic Lidocaine Decreased the Perioperative Opioid Analgesic Requirements but Failed to Reduce Discharge Time After Ambulatory Surgery
Anesthesia & Analgesia, 11/19/09
Article Search
Sponsor